Gastrointestinal Cancer
News
Hepatitis C drove steep rises in cirrhosis, HCC, and related deaths
Cirrhosis nearly doubled among Veterans Affairs patients between 2001 and 2013, while cirrhosis-related mortality rose by about 50% and deaths...
Conference Coverage
Everolimus makes splash in lung, GI neuroendocrine tumors
Key clinical point: Everolimus significantly delays tumor growth in advanced lung and gastrointestinal neuroendocrine tumors. Major finding:...
News
Better outcomes with open surgery vs. laparoscopic for rectal cancer
Concerns about surgical morbidity may favor laparoscopic approaches to rectal cancer surgery, but pathology results suggest open procedures...
Conference Coverage
Radiopeptide therapy sparks unheard of PFS in midgut neuroendocrine tumors
The experimental radiopeptide therapy 177Lu-Dotatate looks poised to become a new treatment option for patients with midgut neuroendocrine tumors...
Conference Coverage
Anal, colorectal, liver cancer rising among HIV positive
The cumulative rates of anal, colorectal, and liver cancers are increasing among HIV-positive patients, mainly because in the antiretroviral era...
News
Narrow-band colonoscopy faster, as sensitive as white light in ulcerative colitis
Key clinical point: The narrow-band method identified similar numbers of intraepithelial cancers in ulcerative colitis patients as white light,...
News
Inflammation points the way to new target in solid tumors
News
Shorter colonoscopies tied to higher colorectal cancer rates
Key clinical point: Colonoscope withdrawal times less than 6 minutes are associated with significantly higher rates of interval colorectal cancer...
News
Fukuoka, Sendai guidelines identified advanced pancreatic neoplasias
Key clinical point: The Sendai and Fukuoka guidelines were equivalent when detecting advanced neoplasias among patients with pancreatic cystic...
Conference Coverage
ESC: New support for aspirin’s anticancer effect
Each of three new case-control studies concluded that daily low-dose aspirin for cardiovascular prevention reduced the risk of developing...
Conference Coverage
ECC: Nivolumab, Cabozantinib bring long overdue options to advanced kidney cancer
Nivolumab significantly extended overall survival in patients with advanced renal cell carcinoma.